Efficacy of topical prednisolone phosphate 1% eye drops in reducing recurrences after bare sclera pterygium surgery
View/ Open
Date
2007Author
Tambe, E
Karimurio, J.
Masinde, S.
Type
ArticleLanguage
enMetadata
Show full item recordAbstract
Aim: To evaluate the efficacy of topical prednisolone phosphate 1% eye drops in
reducing recurrences after bare sclera pterygium surgery.
Design: Randomized controlled clinical trial.
Setting: Kenyatta, Nakuru, Embu, Murang’a, and Machakos eye clinics of Kenya.
Subjects: 51 eyes of 46 patients (17 males and 29 females) operated between May
and November 1997 at the above eye units. The youngest was 22 years and the oldest
76 years.
Results: 24 out of 31 pterygia in the prednisolone group and 15 of 20 controls were
evaluated. 16.7% of the eyes in the prednisolone group developed recurrences as
compared to 53.3% in the control group (p=0.0017). All except one of the recurrences
developed within 8 weeks. Recurrences were more common in younger patients.
There was no statistically significant difference in the recurrence rate between males
and females.
Conclusions: Topical prednisolone phosphate 1% eye drops; a cheap and easily
available eye medication is an effective adjunctive treatment after bare sclera
pterygium surgery.
Recommendations: Other adjunctive treatments and surgical techniques should also
be explored preferably in a multi-centre setup.
Publisher
Department of Ophthalmology, School of Medicine, College of Health Sciences, University Of Nairobi
Subject
bare sclera pterygium surgeryCollections
- Faculty of Health Sciences (FHS) [10377]